ChampionX [CHX] vs Nov [NOV] Detailed Stock Comparison
ChampionX
NASDAQ
Loading...
Nov
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: ChampionX wins in 10 metrics, Nov wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | ChampionX | Nov | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 17.09 | 10.10 | Nov |
| Price-to-Book Ratio | 2.58 | 0.70 | Nov |
| Debt-to-Equity Ratio | 34.38 | 36.15 | ChampionX |
| PEG Ratio | 13.04 | 7.83 | Nov |
| EV/EBITDA | 6.40 | 4.97 | Nov |
| Profit Margin (TTM) | 8.20% | 5.36% | ChampionX |
| Operating Margin (TTM) | 14.42% | 6.54% | ChampionX |
| EBITDA Margin (TTM) | 14.42% | 6.54% | ChampionX |
| Return on Equity | 16.83% | 7.38% | ChampionX |
| Return on Assets (TTM) | 9.44% | 4.45% | ChampionX |
| Free Cash Flow (TTM) | $448.37M | $953.00M | Nov |
| Dividend Yield | 1.90% | 1.52% | ChampionX |
| 1-Year Return | -26.45% | -33.33% | ChampionX |
| Price-to-Sales Ratio (TTM) | 1.38 | 0.52 | Nov |
| Enterprise Value | $4.87B | $5.88B | Nov |
| EV/Revenue Ratio | 1.36 | 0.67 | Nov |
| Gross Profit Margin (TTM) | 33.72% | 20.38% | ChampionX |
| Revenue per Share (TTM) | $19 | $23 | Nov |
| Earnings per Share (Diluted) | $1.51 | $1.21 | ChampionX |
| Beta (Stock Volatility) | 1.51 | 1.33 | Nov |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
ChampionX vs Nov Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| ChampionX | 0.00% | -3.04% | -2.23% | 4.54% | -11.46% | -5.46% |
| Nov | 0.00% | -1.90% | -11.92% | -4.19% | -25.30% | -19.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| ChampionX | -26.45% | 32.97% | 166.63% | -32.08% | -32.08% | -32.08% |
| Nov | -33.33% | -36.09% | -9.30% | -69.91% | -66.58% | -56.06% |
Performance & Financial Health Analysis: ChampionX vs Nov
| Metric | CHX | NOV |
|---|---|---|
| Market Information | ||
| Market Cap | $4.94B | $4.54B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,539,777 | 5,081,620 |
| 90 Day Avg. Volume | 2,969,606 | 4,506,227 |
| Last Close | $25.81 | $11.90 |
| 52 Week Range | $21.92 - $35.94 | $10.84 - $18.40 |
| % from 52W High | -28.19% | -35.33% |
| All-Time High | $46.11 (May 21, 2018) | $86.55 (Sep 01, 2014) |
| % from All-Time High | -44.03% | -86.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | -0.01% |
| Quarterly Earnings Growth | -0.24% | -0.52% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.05% |
| Operating Margin (TTM) | 0.14% | 0.07% |
| Return on Equity (TTM) | 0.17% | 0.07% |
| Debt to Equity (MRQ) | 34.38 | 36.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $10.01 | $17.45 |
| Cash per Share (MRQ) | $2.75 | $2.91 |
| Operating Cash Flow (TTM) | $482.98M | $1.28B |
| Levered Free Cash Flow (TTM) | $252.59M | $821.75M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.90% | 1.52% |
| Last 12-Month Dividend | $0.50 | $0.21 |
Valuation & Enterprise Metrics Analysis: ChampionX vs Nov
| Metric | CHX | NOV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 17.09 | 10.10 |
| Forward P/E | 13.04 | 7.83 |
| PEG Ratio | 13.04 | 7.83 |
| Price to Sales (TTM) | 1.38 | 0.52 |
| Price to Book (MRQ) | 2.58 | 0.70 |
| Market Capitalization | ||
| Market Capitalization | $4.94B | $4.54B |
| Enterprise Value | $4.87B | $5.88B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.36 | 0.67 |
| Enterprise to EBITDA | 6.40 | 4.97 |
| Risk & Other Metrics | ||
| Beta | 1.51 | 1.33 |
| Book Value per Share (MRQ) | $10.01 | $17.45 |
Financial Statements Comparison: ChampionX vs Nov
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CHX | NOV |
|---|---|---|
| Revenue/Sales | $864.46M | $2.10B |
| Cost of Goods Sold | $572.94M | $1.66B |
| Gross Profit | $291.53M | $447.00M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $114.48M | $152.00M |
| EBITDA | $179.17M | $232.00M |
| Pre-Tax Income | $104.41M | $121.00M |
| Income Tax | $15.38M | $47.00M |
| Net Income (Profit) | $89.03M | $74.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CHX | NOV |
|---|---|---|
| Cash & Equivalents | $526.56M | $1.16B |
| Total Current Assets | $1.77B | $5.78B |
| Total Current Liabilities | $784.90M | $2.18B |
| Long-Term Debt | $633.17M | $2.23B |
| Total Shareholders Equity | $1.90B | $6.49B |
| Retained Earnings | $-171.24M | $-583.00M |
| Property, Plant & Equipment | $1.54B | $2.49B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CHX | NOV |
|---|---|---|
| Operating Cash Flow | $63.44M | $280.00M |
| Capital Expenditures | $3.00M | $-84.00M |
| Free Cash Flow | $35.55M | $51.00M |
| Debt Repayment | $-5.38M | $-4.00M |
| Common Stock Repurchase | $0 | $-81.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CHX | NOV |
|---|---|---|
| Shares Short | 4.50M | 29.95M |
| Short Ratio | 1.56 | 6.57 |
| Short % of Float | 0.03% | 0.18% |
| Average Daily Volume (10 Day) | 2,539,777 | 5,081,620 |
| Average Daily Volume (90 Day) | 2,969,606 | 4,506,227 |
| Shares Outstanding | 190.70M | 381.55M |
| Float Shares | 189.36M | 368.04M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.96% | 1.07% |
Dividend Analysis & Yield Comparison: ChampionX vs Nov
| Metric | CHX | NOV |
|---|---|---|
| Last 12-Month Dividend | $0.50 | $0.21 |
| Last 12-Month Dividend Yield | 1.90% | 1.52% |
| 3-Year Avg Annual Dividend | $0.39 | $0.21 |
| 3-Year Avg Dividend Yield | 0.31% | 0.35% |
| 3-Year Total Dividends | $1.17 | $0.63 |
| Ex-Dividend Date | Jul 03, 2025 | Mar 14, 2025 |